• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝氮烯:引发新问题的古老药物类别。

Nitazenes: An Old Drug Class Causing New Problems.

作者信息

Schwarz Evan S, Dicker Frank, Lothet Emilie, Spungen Hannah, Levine Michael

机构信息

Division of Medical Toxicology, Department of Emergency Medicine, University of California, Los Angeles, California, USA.

Division of Medical Toxicology, Department of Emergency Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

出版信息

Mo Med. 2025 Jul-Aug;122(4):329-333.

PMID:40787029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12331301/
Abstract

The illicit opioid supply is increasingly adulterated with novel synthetic opioids such as nitazenes. Nitazenes are very potent opioids and are increasingly associated with opioid overdoses and deaths. Despite their potency, nitazenes are reversed by naloxone. Given the high risk of overdose associated with these agents, improvements in the delivery of addiction care and naloxone distribution are needed to prevent morbidity and mortality from nitazenes and other novel opioids.

摘要

非法阿片类药物供应越来越多地被新型合成阿片类药物(如氮杂环庚三烯类)掺杂。氮杂环庚三烯类是非常强效的阿片类药物,并且越来越多地与阿片类药物过量及死亡相关联。尽管它们效力很强,但氮杂环庚三烯类可被纳洛酮逆转。鉴于与这些药物相关的过量用药高风险,需要改进成瘾护理服务的提供以及纳洛酮的分发,以预防因氮杂环庚三烯类和其他新型阿片类药物导致的发病和死亡。

相似文献

1
Nitazenes: An Old Drug Class Causing New Problems.硝氮烯:引发新问题的古老药物类别。
Mo Med. 2025 Jul-Aug;122(4):329-333.
2
Nitazenes: review of comparative pharmacology and antagonist action.硝氮烯类:比较药理学与拮抗作用综述
Clin Toxicol (Phila). 2025 Jun;63(6):393-406. doi: 10.1080/15563650.2025.2504133. Epub 2025 May 27.
3
Implementation of Medication Disposal Programs and Availability of Same-Day Naloxone at Community Pharmacies: Protocol for a Secret Shopper Caller Approach.社区药房药物处置计划的实施及同日纳洛酮的可及性:秘密购物者致电法方案
JMIR Res Protoc. 2025 Jun 10;14:e64344. doi: 10.2196/64344.
4
Intranasal overdose reversal formulations: a rapid review of available agents.鼻内过量解毒制剂:现有药物的快速综述。
Pain Manag. 2025 Feb;15(2):105-113. doi: 10.1080/17581869.2025.2461445. Epub 2025 Feb 4.
5
Naloxone Effectiveness: A Systematic Review.纳洛酮的有效性:一项系统评价。
J Addict Nurs. 2018 Jul/Sep;29(3):167-171. doi: 10.1097/JAN.0000000000000230.
6
The opportunity to save a life: A qualitative study of a point-of-care overdose education and naloxone distribution intervention.挽救生命的契机:一项关于即时护理过量用药教育及纳洛酮分发干预措施的定性研究
PLoS One. 2025 Jun 25;20(6):e0326495. doi: 10.1371/journal.pone.0326495. eCollection 2025.
7
Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial.社区康复干预与死亡率:包括多药物过量死亡的随机临床试验。
JAMA Netw Open. 2024 Oct 1;7(10):e2440006. doi: 10.1001/jamanetworkopen.2024.40006.
8
Opioid Education and Naloxone Distribution by Occupation: A Scoping Review.按职业划分的阿片类药物教育与纳洛酮分发:一项范围综述
Workplace Health Saf. 2025 Jul;73(7):324-356. doi: 10.1177/21650799251326109. Epub 2025 Mar 27.
9
Do heroin overdose patients require observation after receiving naloxone?海洛因过量患者在接受纳洛酮治疗后需要观察吗?
Clin Toxicol (Phila). 2017 Feb;55(2):81-87. doi: 10.1080/15563650.2016.1253846. Epub 2016 Nov 16.
10
Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria.带回家的纳洛酮项目有效吗?运用布拉德福德·希尔标准进行的系统评价。
Addiction. 2016 Jul;111(7):1177-87. doi: 10.1111/add.13326. Epub 2016 Mar 30.

本文引用的文献

1
Metabolic characterization of the new benzimidazole synthetic opioids - nitazenes.新型苯并咪唑合成阿片类药物——硝氮烯的代谢特征
Front Pharmacol. 2024 Jul 18;15:1434573. doi: 10.3389/fphar.2024.1434573. eCollection 2024.
2
Notes from the Field: Detection of Medetomidine Among Patients Evaluated in Emergency Departments for Suspected Opioid Overdoses - Missouri, Colorado, and Pennsylvania, September 2020-December 2023.实地记录:2020年9月至2023年12月在密苏里州、科罗拉多州和宾夕法尼亚州急诊科因疑似阿片类药物过量接受评估的患者中检测到美托咪定
MMWR Morb Mortal Wkly Rep. 2024 Aug 1;73(30):672-674. doi: 10.15585/mmwr.mm7330a3.
3
Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.事实与虚构:纳洛酮在当前合成阿片类药物时代治疗阿片类药物引起的呼吸抑制。
Front Public Health. 2024 Feb 28;12:1346109. doi: 10.3389/fpubh.2024.1346109. eCollection 2024.
4
Nitazenes-heralding a second wave for the UK drug-related death crisis?硝氮烯——英国毒品相关死亡危机的第二波预警?
Lancet Public Health. 2024 Feb;9(2):e71-e72. doi: 10.1016/S2468-2667(24)00001-X. Epub 2024 Jan 12.
5
Evolving use of recreational drugs in UK-nitazenes and xylazine.英国娱乐性药物使用的演变——氮杂环丁二烯和赛拉嗪。
BMJ. 2023 Nov 7;383:2604. doi: 10.1136/bmj.p2604.
6
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients.纳洛酮在急诊科新型强效阿片类药物和芬太尼过量中的应用。
JAMA Netw Open. 2023 Aug 1;6(8):e2331264. doi: 10.1001/jamanetworkopen.2023.31264.
7
Old Drugs and New Challenges: A Narrative Review of Nitazenes.老药与新挑战:硝氮烯类药物的叙述性综述
Cureus. 2023 Jun 21;15(6):e40736. doi: 10.7759/cureus.40736. eCollection 2023 Jun.
8
Non-fentanyl new synthetic opioids - An update.非芬太尼类新合成阿片类物质——最新进展。
Forensic Sci Int. 2023 Aug;349:111775. doi: 10.1016/j.forsciint.2023.111775. Epub 2023 Jun 28.
9
Mu-opioid receptor selective superagonists produce prolonged respiratory depression.μ-阿片受体选择性超级激动剂会导致长时间的呼吸抑制。
iScience. 2023 Jun 13;26(7):107121. doi: 10.1016/j.isci.2023.107121. eCollection 2023 Jul 21.
10
Rapid screening of 2-benzylbenzimidazole nitazene analogs in suspect counterfeit tablets using Raman, SERS, DART-TD-MS, and FT-IR.采用拉曼、SERS、DART-TD-MS 和 FT-IR 技术快速筛选疑似假冒片剂中的 2-苄基苯并咪唑硝噻嗪类似物。
Drug Test Anal. 2023 May;15(5):539-550. doi: 10.1002/dta.3440. Epub 2023 Feb 5.